The 2nd Ligase Targeting Drug Development Summit returns virtually with new insight and data from pioneers in the field to delve deep into ligase biology, assays to investigate functions as well as screening tools for optimum ligand identification and validation.
This forum will provide an unrivalled meeting-point for industry leaders, in order to strategically accelerate and de-risk the process of identifying, validating and therapeutically leveraging cell and tissue specific Ubiquitin E3 ligases for degradation or modulation of targets of interest.
This forum will provide an unrivalled meeting-point for industry leaders, in order to strategically accelerate and de-risk the process of identifying, validating and therapeutically leveraging cell and tissue specific Ubiquitin E3 ligases for degradation or modulation of targets of interest.
